Reports for FRESENIUS KABI CANADA LTD
Company Name
FRESENIUS KABI CANADA LTD
Totals |
||
Shortage reports |
328 |
|
| Actual shortage: | 10 (3%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 5 (2%) | |
| Resolved: | 312 (95%) | |
Discontinuation Reports |
2 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
50 (15%) |
|
Overdue reports |
4 (36%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| INTRALIPID 20% | 20% | EMULSION | Resolved | 2021-09-10 | 2021-10-22 | 145481 |
| ISOFLURANE USP | 99.9% | LIQUID | Resolved | 2024-07-31 | 2024-08-10 | 234157 |
| ISOFLURANE USP | 99.9% | LIQUID | Resolved | 2024-07-31 | 2024-08-10 | 234160 |
| ISOFLURANE USP | 99.9% | LIQUID | Resolved | 2024-07-31 | 2024-08-10 | 234163 |
| MIDAZOLAM INJECTION | 5MG | LIQUID | Resolved | 2018-01-19 | 2018-08-10 | 36712 |
| MIDAZOLAM INJECTION | 5MG | LIQUID | Resolved | 2018-01-19 | 2018-03-30 | 36716 |
| MIDAZOLAM INJECTION | 5MG | LIQUID | Resolved | 2018-04-23 | 2018-05-24 | 47018 |
| MIDAZOLAM INJECTION | 5MG | LIQUID | Resolved | 2019-01-22 | 2019-07-26 | 73217 |
| MIDAZOLAM INJECTION | 5MG | LIQUID | Resolved | 2019-04-09 | 2019-07-26 | 80849 |
| MIDAZOLAM INJECTION | 5MG | LIQUID | Resolved | 2020-04-20 | 2020-06-18 | 112478 |
| MIDAZOLAM INJECTION | 5MG | LIQUID | Resolved | 2020-08-04 | 2020-09-19 | 121647 |
| MIDAZOLAM INJECTION | 5MG | LIQUID | Resolved | 2021-11-12 | 2021-12-31 | 149177 |
| MIDAZOLAM INJECTION | 5MG | LIQUID | Resolved | 2021-12-17 | 2022-03-19 | 151515 |
| MIDAZOLAM INJECTION | 5MG | LIQUID | Resolved | 2022-04-13 | 2022-05-01 | 158771 |
| MIDAZOLAM INJECTION | 5MG | LIQUID | Avoided shortage | 2022-04-28 | 2022-06-01 | 159557 |
| MIDAZOLAM INJECTION | 5MG | LIQUID | Resolved | 2023-01-02 | 2023-04-03 | 179688 |
| DIPYRIDAMOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2018-08-24 | 2018-09-06 | 59148 |
| DIPYRIDAMOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2018-12-13 | 2019-03-26 | 69542 |
| DIPYRIDAMOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2019-07-05 | 2019-10-02 | 88601 |
| DIPYRIDAMOLE INJECTION, USP | 5MG | LIQUID | Resolved | 2020-01-20 | 2020-02-13 | 103733 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.5G 36G | POWDER FOR SOLUTION | Discontinued | 2024-08-13 | 2024-08-20 | 235203 |
| SODIUM BICARBONATE INJECTION, USP | 42MG | SOLUTION | Discontinued | 2024-10-03 | 2024-10-03 | 239180 |
Showing 1 to 2 of 2